Tamil Arasu

FDA investigator

Appears on 27 documents from 2011 to 2025, mostly at sites in India. Most often cites production record review (21 CFR 211.192).

27
Documents on file
4.4
Observations per 483
2011
First seen
2025
Most recent

What they cite most

From 120 observations

Activity by year

2011: 1, 2015: 3, 2016: 1, 2017: 3, 2018: 2, 2019: 6, 2020: 1, 2023: 1, 2024: 5, 2025: 4

Where

India 17 · New Jersey 5 · Ireland 1 · Italy 1 · Mexico 1 · Singapore 1

Is Tamil Arasu coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

27 documents, newest first
FirmOpen
483 Hetero Labs Limited, Unit-EXSep 26, 2025 · Narasapmam Village, India
483 Intas Pharmaceuti cal s Li mi tedSep 17, 2025 · Dehradun, India
483 Glenmark Pharmaceuticals LtdFeb 14, 2025 · Pithampur, India
483 Allergan Pharmaceuticals IrelandJan 30, 2025 · Westport, Ireland
483 Haw Par Healthcare Ltd.Sep 27, 2024 · Singapore, Singapore
483 Cipla LimitedJun 21, 2024 · Verna, India
483 Dr . Reddy' s Laboratori.es Limited CTO -Jun 7, 2024 · Pydibhimavaram, India

About this profile

What does Tamil Arasu inspect?

Tamil Arasu appears on 27 documents on file covering 24 sites, mostly in India.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.113 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Tamil Arasu is dated Sep 26, 2025.